
Juno Therapeutics
North America, Washington, United States, Seattle
Description
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Investor Profile
Juno Therapeutics has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Oncology.
Stage Focus
- Series B (33%)
- Series A (33%)
- Series Unknown (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
- Therapeutics
- Genetics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.